Evidence map›Paper›PMID 41358317›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Leveraging and partitioning polygenic risk scores to identify cancer-related proteins.

Diptavo Dutta, Jingning Zhang, Xinyu Guo, Mitchell Machiela, Kevin Brown, Josef Coresh, Alexis Battle, Elizabeth A Platz, Nilanjan Chatterjee

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Diptavo DuttaIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA.ORCID 0000-0002-6634-9040
Jingning ZhangDepartment of Biostatistics, Johns Hopkins University, USA.
Xinyu GuoDepartment of Quantitative and Computational Biology, University of Southern California, USA.
Mitchell MachielaIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA.
Kevin BrownLaboratory of Translational Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA.
Josef CoreshDepartment of Biostatistics, Johns Hopkins University, USA.
Alexis BattleIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA.
Elizabeth A PlatzDepartment of Epidemiology, Johns Hopkins University, USA.
Nilanjan ChatterjeeDepartment of Biostatistics, Johns Hopkins University, USA.

Funding

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID · 2022 to 2025
$13.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2022 to 2025
$5.1M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2022 to 2025
$5.0M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI WINDHAM, BEVERLY GWEN · 2022 to 2025
$4.8M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CORESH, JOSEF · 2022 to 2025
$4.7M
Enhancing ARIC Infrastructure to Yield a New Cancer Epidemiology CohortU01CA164975 · NCI · JOHNS HOPKINS UNIVERSITY · PI PLATZ, ELIZABETH A. · 2012 to 2018
$3.8M
Modeling the dynamicimpact of rare and common genetic variation on gene expression anddiseaseR35GM139580 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BATTLE, ALEXIS · 2021 to 2025
$3.1M
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular DiseaseR01HL134320 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL, SELVIN, ELIZABETH · 2016 to 2019
$3.1M
Robust Methods for Polygenic Analysis to Inform Disease Etiology and Enhance Risk PredictionR01HG010480 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI CHATTERJEE, NILANJAN · 2019 to 2023
$2.8M
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversityU01CA249866 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHATTERJEE, NILANJAN · 2020 to 2023
$2.3M
Statistical Methods for Data Integration and Applications to Genome-wide Association StudiesR01HG013137 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI Nilanjan Chatterjee · 2024 to 2026
$843k
NCI NIH HHS U01 CA164975NCI NIH HHS U01 CA249866NHGRI NIH HHS R01 HG010480NHGRI NIH HHS R01 HG013137NHLBI NIH HHS 75N92022D00001NHLBI NIH HHS 75N92022D00002NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS 75N92022D00004NHLBI NIH HHS 75N92022D00005NHLBI NIH HHS R01 HL134320NIGMS NIH HHS R35 GM139580
6 · The paper itself

Abstract

Background: Large-scale genome-wide association studies (GWAS) have identified numerous common susceptibility variants associated with various cancers but underlying molecular mechanisms remain largely unknown. Methods: Here we investigated the associations of susceptibility SNPs from 21 cancers with 4,955 plasma protein levels measured in cancer-free participants (N=8,664) from the Atherosclerosis Risk in Communities (ARIC) study. We used two complementary approaches, one based on analysis of associations of polygenic risk scores with the plasma proteome (pQTS) and the other based on a sparse canonical correlation analysis of the cancer-associated SNPs with the plasma proteome (ARCHIE), to detect potential mediating proteins and sub-networks. Results: Across all cancers, we identified 90 associated proteins using pQTS of which 53 were distal ( Conclusion: Our analysis leverages known GWAS associations for cancers to identify protein networks underlying cancer risk and accordingly partition polygenic risk scores into mechanistic components. As detailed molecular data of relevant tissues, cell-types and developmental stage become increasingly available, similar approaches will prove to be important for identifying downstream molecular targets for GWAS variants and improve interpretation and research application of polygenic risk scores.

Identifiers

PMID41358317
PMCPMC12676551

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.